USSTOCK.TODAY
Market Closed
Log in Sign up

Can-Fite Biopharma Ltd ADR(CANF) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

CANF
CANF
Can-Fite Biopharma Ltd ADR
At close Nov 19 at 3:59 PM ET (Korea 11/20 05:59)
$1.47
-0.04 ▼ -2.69%
Nov 19 at 4:37 PM ET (Korea 11/20 06:37)
$1.48
+0.01 ▲ +0.75%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -6.3Insider Own ⓘ -Shs Outstand ⓘ 0.2MPerf Week ⓘ -1.38%
Market Cap ⓘ 0.00BForward P/E ⓘ -EPS next Y ⓘ 55.39%Insider Trans ⓘ -Shs Float ⓘ -Perf Month ⓘ -22.24%
Enterprise Value ⓘ -0.00BPEG ⓘ -EPS next Q ⓘ -0.8Inst Own ⓘ 5%Short Float ⓘ -Perf Quarter ⓘ -55.87%
Income ⓘ -0.01BP/S ⓘ 11.25EPS this Y ⓘ 65.83%Inst Trans ⓘ -3.42%Short Ratio ⓘ 0.08Perf Half Y ⓘ -57.28%
Sales ⓘ 0.00BP/B ⓘ 0.65EPS next 5Y ⓘ 52.5%ROA ⓘ -121.89%Short Interest ⓘ 0.03MPerf YTD ⓘ -63.26%
Book/sh ⓘ 2.27P/C ⓘ 0.66EPS past 3/5Y ⓘ 45.54% 45.72%ROE ⓘ -212.72%52W High ⓘ -85.87% ($10.40)Perf Year ⓘ -77.8%
Cash/sh ⓘ 2.24P/FCF ⓘ -Sales past 3/5Y ⓘ -20.32% -11.88%ROIC ⓘ -197.98%52W Low ⓘ 3.48% ($1.42)Perf 3Y ⓘ -96.29%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 82.96%Gross Margin ⓘ 99.51%Volatility(W/M) ⓘ 6.82% 6.17%Perf 5Y ⓘ -99.39%
Dividend TTM ⓘ -EV/Sales ⓘ -5.8Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -2402.92%ATR (14) ⓘ 0.1Perf 10Y ⓘ -99.98%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 3.6EPS Q/Q ⓘ 66.85%Profit Margin ⓘ -2358.72%RSI (14) ⓘ 33.09Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 3.6Sales Q/Q ⓘ -20.25%SMA20 ⓘ -8.42% ($1.61)Beta ⓘ 1.19Target Price ⓘ $8
Payout ⓘ -Debt/Eq ⓘ 0.01Earnings ⓘ 2026/9/8SMA50 ⓘ -22.53% ($1.9)Rel Volume ⓘ 0.04Prev Close ⓘ $1.51
Employees ⓘ 5LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -51.45% ($3.03)Avg Volume(3M) ⓘ 0.37MPrice ⓘ $1.47
IPO ⓘ 2012/11/1Option/Short ⓘ No/YesTrades ⓘ 142Volume ⓘ 15,304Change ⓘ -2.69%
Company
CANF CANFCan-Fite Biopharma Ltd ADR | AMEX | Biotechnology Deep dive

🧪 This Israel-based clinical-stage biotech holds two small-molecule drug candidates targeting the A3 adenosine receptor (A3AR)—piclidenoson and namodenoson—as its core assets. It is a micro-cap ADR running late-stage clinical trials across a broad range of indications, including liver cancer, psoriasis, pancreatic cancer, and MASH.

Quote

Over the past 1 year, on the lower side

86% below its 1-year high.

Now $1.47
52w low$1.4252w high$10.40
52W Range1%
Volume ⓘ 15,304

Traded less than usual. That is 4% of its average volume.

C
Overall · average, with some caution
We judged 6 of the 8 questions below. 1 rate excellent and 2 need caution.
No data for earnings, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #544 of 598 in the industry

Based on market cap of $5M.

FAQ

FAQ

What kind of company is CANF?

CANF belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of CANF?

The market cap of CANF is approximately $5M, ranking 5,582 within its sector.

What is the 52-week high and low for CANF?

CANF has recorded a 52-week high of $10.40 and a low of $1.42.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels